Procurement of Specialized Pharmaceutical Drugs for Indian Army Medical Services

Work Description - NA

This tender, identified by Bid Number GEM/2026/B/7820728, is being issued by the Department of Military Affairs, under the Ministry of Defence, for the Indian Army, with the specified office located in Lucknow. The procurement encompasses a comprehensive list of pharmaceutical items, including Gilteritinib 40 mg tablets, Asciminib 40 mg tablets, Acalabrutinib 100mg tablets, various injectable medications such as Obinutuzumab 1000 mg per 40ml, Brentuximab vedotin 50 mg vial, FIEBA Factor VIII Inhibitor bypass complex, Romiplostin 500 mcg, Eculizumab 300MG 10 mg per ml, Polatuzumab vedotin 30 mg, Luspatercept (both 75 mg and 25 mg injections), Pentaglobulin 100 ml IgM enriched Immunoglobulin, Teclistamab 30 mg 3mL 10mg per mL, Teclistamab-cqyv 153 mg Vial, and Fosnetupitant 235 mg and Palonosetron 0.25mg injection. Additionally, the tender includes Pomalidomide 4mg tablets, All-trans-retinoic Acid 10mg capsules, and Megestrol 40 mg per ml syrup in a 120 ml bottle, as well as Ivosidenib 250 mg tablets. The total quantity required across all these items is 3597 units. Prospective bidders are advised that the bid submission window opens on August 7, 2026, at 3:22 PM and closes on August 28, 2026, at 4:00 PM.